<!DOCTYPE html>
<html lang="en">
<head>
  <!-- Google tag (gtag.js) -->
  <script async src="https://www.googletagmanager.com/gtag/js?id=G-LSRR4KW715"></script>
  <script>
    window.dataLayer = window.dataLayer || [];
    function gtag(){dataLayer.push(arguments);
    }
    gtag('js', new Date());

    gtag('config', 'G-LSRR4KW715');
  </script>


  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>Case 29.5 - Premature Ovarian Insufficiency [SDL]</title>

  <!-- Favicon -->
  <link rel="icon" type="image/png" href="../assets/ShepTech logo.png">
  <link rel="apple-touch-icon" href="../assets/ShepTech logo.png">

  <!-- Primary Meta Tags -->
  <meta name="title" content="Case 29.5 - Premature Ovarian Insufficiency [SDL] | MD3 SCP Cases">
  <meta name="description" content="Self-directed learning case on premature ovarian insufficiency (POI) covering diagnosis, causes, long-term health implications, and management.">

  <!-- Open Graph / Facebook -->
  <meta property="fb:app_id" content="your_facebook_app_id">
  <meta property="og:type" content="article">
  <meta property="og:url" content="https://md3-scp.netlify.app/cases/case29_5.html">
  <meta property="og:title" content="Case 29.5 - Premature Ovarian Insufficiency [SDL]">
  <meta property="og:site_name" content="MD3 SCP Cases">
  <meta property="og:description" content="Self-directed learning case on premature ovarian insufficiency (POI) covering diagnosis, causes, long-term health implications, and management.">
  <meta property="og:image" content="https://md3-scp.netlify.app/assets/ShepTech%20logo.png">
  <!-- Twitter -->
  <meta property="twitter:card" content="summary">
  <meta property="twitter:title" content="Case 29.5 - Premature Ovarian Insufficiency [SDL]">
  <meta property="twitter:description" content="Self-directed learning case on premature ovarian insufficiency (POI) covering diagnosis, causes, long-term health implications, and management.">
  <meta property="twitter:image" content="https://md3-scp.netlify.app/assets/ShepTech%20logo.png">

  <link rel="stylesheet" href="../css/case.css">

  <!-- Firebase SDK -->
  <script src="https://www.gstatic.com/firebasejs/9.22.0/firebase-app-compat.js"></script>
  <script src="https://www.gstatic.com/firebasejs/9.22.0/firebase-auth-compat.js"></script>
  <script src="https://www.gstatic.com/firebasejs/9.22.0/firebase-firestore-compat.js"></script>
</head>
<body>
  <div class="container">
    <div class="case-header">
      <a href="#" class="back-link" onclick="goBack(event)">← Back to Cases</a>
    </div>

    <h1>Case 29.5 – Premature Ovarian Insufficiency [SDL]</h1>
    <p class="meta"><strong>Category:</strong> Medicine | <strong>Discipline:</strong> Obstetrics & Gynaecology | <strong>Setting:</strong> Self-Directed Learning</p>

    <h2>Learning Objectives</h2>
    <p>This is a <strong>self-directed learning (SDL)</strong> case. Use the key learning points below to guide your independent study of premature ovarian insufficiency.</p>

    <h2>Key Topics to Cover</h2>
    <div class="key-points">
      <ul>
        <li><strong>Definition:</strong> Premature ovarian insufficiency (POI) = menopause before age 40 (affects 1% of women) - previously called "premature menopause" or "premature ovarian failure"</li>
        <li><strong>Early menopause:</strong> Menopause age 40-45 (affects 5% of women) - managed similarly to POI</li>
        <li><strong>Causes of POI:</strong>
          <ul>
            <li><strong>Idiopathic (50-90%):</strong> No identifiable cause - most common</li>
            <li><strong>Genetic:</strong> Turner syndrome (45,XO), Fragile X premutation (FMR1 gene - 2-6% of POI), familial (family history of early menopause)</li>
            <li><strong>Autoimmune:</strong> Autoimmune polyglandular syndrome (associated with Addison's disease, hypothyroidism, T1DM), autoimmune oophoritis</li>
            <li><strong>Iatrogenic:</strong> Chemotherapy (alkylating agents, cyclophosphamide), radiotherapy (pelvic radiation), bilateral oophorectomy</li>
            <li><strong>Infections:</strong> Mumps oophoritis (rare)</li>
          </ul>
        </li>
        <li><strong>Diagnosis (ALL women &lt;40 years with amenorrhoea/oligomenorrhoea):</strong>
          <ul>
            <li><strong>FSH >30 IU/L on 2 occasions</strong> (4-6 weeks apart) + amenorrhoea/oligomenorrhoea for ≥4 months</li>
            <li><strong>Oestradiol low</strong> (usually &lt;100 pmol/L)</li>
            <li><strong>Exclude pregnancy first</strong> (βhCG)</li>
            <li><strong>Do NOT diagnose menopause in women &lt;40 based on symptoms alone</strong> - FSH testing required</li>
          </ul>
        </li>
        <li><strong>Investigations (identify underlying cause):</strong>
          <ul>
            <li><strong>Karyotype:</strong> Exclude Turner syndrome (45,XO), Turner mosaicism (45,XO/46,XX)</li>
            <li><strong>FMR1 gene testing:</strong> Fragile X premutation (offer genetic counselling if positive - risk of fragile X syndrome in offspring)</li>
            <li><strong>Autoimmune screen:</strong> TFTs, 9am cortisol, anti-adrenal antibodies, anti-thyroid antibodies, glucose (exclude autoimmune polyglandular syndrome)</li>
            <li><strong>Pelvic USS:</strong> Assess ovarian morphology</li>
          </ul>
        </li>
        <li><strong>Symptoms:</strong> Same as menopause - vasomotor symptoms (hot flushes, night sweats), vaginal dryness, low mood, reduced libido, amenorrhoea/oligomenorrhoea</li>
        <li><strong>Long-term health consequences (MORE SEVERE than menopause at normal age):</strong>
          <ul>
            <li><strong>Osteoporosis:</strong> Prolonged oestrogen deficiency → ↑ bone loss → ↑ fracture risk (offer DEXA scan at diagnosis)</li>
            <li><strong>Cardiovascular disease:</strong> Loss of oestrogen's cardioprotective effect → ↑ CVD risk (relative risk 2-3x higher)</li>
            <li><strong>Cognitive decline:</strong> Possible ↑ risk of dementia (evidence conflicting)</li>
            <li><strong>Psychological impact:</strong> Infertility distress, loss of femininity, anxiety, depression</li>
            <li><strong>Infertility:</strong> Spontaneous pregnancy rare (5-10% conceive spontaneously after diagnosis) - most require egg donation IVF</li>
          </ul>
        </li>
        <li><strong>Management (NICE 2015 / BMS Guidelines):</strong>
          <ul>
            <li><strong>HRT (oestrogen + progestogen) - STRONGLY RECOMMENDED until age 51 (average age of natural menopause):</strong>
              <ul>
                <li><strong>Indication:</strong> Replace physiological oestrogen (not just symptom control) - prevent osteoporosis, CVD</li>
                <li><strong>Duration:</strong> Continue until age 51 (minimum) - then reassess (no increased breast cancer risk before age 51)</li>
                <li><strong>Combined oral contraceptive pill (COCP):</strong> Alternative to HRT (provides contraception + oestrogen replacement) - suitable for young women</li>
                <li><strong>Transdermal HRT preferred if:</strong> BMI >30, VTE risk factors, migraines</li>
              </ul>
            </li>
            <li><strong>Bone protection:</strong> DEXA scan at diagnosis, calcium 1000-1200mg/day, vitamin D 10mcg/day (400 IU), weight-bearing exercise</li>
            <li><strong>Cardiovascular risk reduction:</strong> Optimize CV risk factors (smoking cessation, healthy diet, exercise, manage BP/cholesterol)</li>
            <li><strong>Fertility counselling:</strong>
              <ul>
                <li>Spontaneous pregnancy possible (5-10%) but unpredictable - <strong>contraception still required if pregnancy not desired</strong></li>
                <li>Egg donation IVF = most effective treatment for infertility (success rate 40-50% per cycle)</li>
                <li>Fertility preservation NOT possible (ovarian reserve already depleted at diagnosis)</li>
                <li>Refer to specialist fertility clinic</li>
              </ul>
            </li>
            <li><strong>Psychological support:</strong> Counselling, support groups (e.g., Daisy Network - UK POI charity), address fertility distress</li>
          </ul>
        </li>
        <li><strong>Key counselling points:</strong>
          <ul>
            <li><strong>HRT is ESSENTIAL (not optional)</strong> - protect bones and heart</li>
            <li><strong>No increased breast cancer risk with HRT before age 51</strong> (replacing physiological oestrogen, not adding excess)</li>
            <li><strong>Fertility highly unlikely but not impossible</strong> - egg donation IVF main option</li>
            <li><strong>Long-term follow-up required:</strong> Monitor bone health, cardiovascular risk</li>
          </ul>
        </li>
      </ul>
    </div>

    <h2>Recommended Resources</h2>
    <p>Refer to your lecture notes, textbooks (e.g., Oxford Handbook of Obstetrics & Gynaecology), and online resources (NICE guidelines 2015, British Menopause Society guidelines, Daisy Network) to explore these topics in detail.</p>

  </div>

  <!-- JavaScript -->  <script src="../js/firebase-config.js"></script>
  <script src="../js/dark-mode.js"></script>
  <script src="../js/auth.js"></script>
  <script src="../js/user-analytics.js"></script>
  <script src="../js/analytics-integration.js"></script>
  <script src="../js/completion-tracker.js"></script>
  <script src="../js/flag-tracker.js"></script>
  <script src="../js/case-interactions.js"></script>

  <script>
    // Toggle case completion
    function toggleCaseCompletion() {
      if (window.completionTracker) {
        const caseId = window.completionTracker.getCurrentCaseId();
        if (caseId) {
          window.completionTracker.toggleCompletion(caseId);
        
    }
      
    }
    
    }
// Toggle case flag
    function toggleCaseFlag() {
      console.log('toggleCaseFlag() function called');
      console.log('window.flagTracker exists:', !!window.flagTracker);

      if (!window.flagTracker) {
        console.error('window.flagTracker is not defined!');
        alert('Flag tracker not initialized. Please refresh the page.');
        return;
      
    }

      const caseId = window.flagTracker.getCurrentCaseId();
      console.log('Current case ID:', caseId);

      if (!caseId) {
        console.error('Could not get case ID');
        alert('Could not determine case ID');
        return;
      
    }

      console.log('Calling window.flagTracker.toggleCaseFlag with caseId:', caseId);
      window.flagTracker.toggleCaseFlag(caseId);
    
    }

    // Update case flag button state on page load
    document.addEventListener('DOMContentLoaded', () => {
      if (window.flagTracker) {
        setTimeout(() => {
          const caseId = window.flagTracker.getCurrentCaseId();
          if (caseId) {
            window.flagTracker.updateCaseFlagButton(caseId);
          
    }
        }, 100);
      
    }
    });
    
    }
  </script>

</body>
</html>
